Development of a peptide-based bifunctional chelator conjugated to a cytotoxic drug for the treatment of melanotic melanoma.

Abstract:

:The cytotoxic drug gemcitabine (GEM) has been conjugated to receptor-binding peptides to target melanoma tumors. A hexapeptide having a Lys-Gly-His-Lys sequence (pep-1), an octapeptide with an Arg-Gly-Asp-Lys-Gly-His-Lys sequence (pep-2), a GEM-conjugated Lys-Gly-His-Lys peptide (GEM-pep-3) and a GEM-conjugated Asp-Gly-Arg peptide (GEM-pep-4) were synthesized and characterized. In vitro uptake of fluorescently labeled GEM-pep-3 and GEM-pep-4 on B16F10 cells was investigated. Fluorescence microscopy studies demonstrated significant uptake of GEM-pep-3 in the B16F10 mouse melanoma cell line. The peptides and GEM-coupled peptides were radiolabeled with [99mTc(CO)3(H2O)3]+ and examined for in vitro cell binding in the B16F10 melanoma cell line and in vivo biodistribution and scintigraphic studies in a B16F10 melanoma tumor-bearing mice model. In vitro cellular uptake studies and biological evaluation confirmed significant deposition of GEM-pep-3 at the melanoma tumor site. The MTT assay depicted higher cytotoxic behaviour of GEM-pep-3 than free GEM. A considerable amount of cell apoptosis was also observed in B16F10 cells. Finally, the in vivo therapeutic efficacy study revealed a significant decrease in tumor growth in the GEM-pep-3-treated animal model. These studies reveal enough potentiality of GEM-pep-3 to treat melanoma and underline the need for further evaluation.

journal_name

Medchemcomm

journal_title

MedChemComm

authors

Gaonkar RH,Baishya R,Paul B,Dewanjee S,Ganguly S,Debnath MC,Ganguly S

doi

10.1039/c7md00638a

subject

Has Abstract

pub_date

2018-03-06 00:00:00

pages

812-826

issue

5

eissn

2040-2503

issn

2040-2511

pii

c7md00638a

journal_volume

9

pub_type

杂志文章
  • Inhibition of Ras-Effector Interaction by Cyclic Peptides.

    abstract::A combinatorial library of 6 × 106 cyclic peptides was synthesized in the one bead-two compound format, with each bead displaying a unique cyclic peptide on its surface and a linear peptide encoding tag in its interior. Screening of the library against K-Ras identified compounds that bound K-Ras with submicromolar aff...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C2MD20329D

    authors: Wu X,Upadhyaya P,Villalona-Calero MA,Briesewitz R,Pei D

    更新日期:2013-02-01 00:00:00

  • Synthesis and biological activity evaluation of novel peroxo-bridged derivatives as potential anti-hepatitis B virus agents.

    abstract::Previous studies have demonstrated that natural steroid compounds containing a peroxide bridge exhibited potential anti-hepatitis B virus activity. To continue our research, a simple and regioselective methodology, using Eosin Y as a clean photosensitized oxidation catalyst, was developed for the synthesis of a peroxi...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c6md00344c

    authors: Jia M,Zhao R,Xu B,Yan W,Chu F,Gu H,Xie T,Xiang H,Ren J,Chen D,Wang P,Lei H

    更新日期:2016-10-19 00:00:00

  • Open PHACTS computational protocols for in silico target validation of cellular phenotypic screens: knowing the knowns.

    abstract::Phenotypic screening is in a renaissance phase and is expected by many academic and industry leaders to accelerate the discovery of new drugs for new biology. Given that phenotypic screening is per definition target agnostic, the emphasis of in silico and in vitro follow-up work is on the exploration of possible molec...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c6md00065g

    authors: Digles D,Zdrazil B,Neefs JM,Van Vlijmen H,Herhaus C,Caracoti A,Brea J,Roibás B,Loza MI,Queralt-Rosinach N,Furlong LI,Gaulton A,Bartek L,Senger S,Chichester C,Engkvist O,Evelo CT,Franklin NI,Marren D,Ecker GF,Jacob

    更新日期:2016-06-01 00:00:00

  • Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma.

    abstract::Transcriptomic phenotypes defined for melanoma have been reported to correlate with sensitivity to various drugs. In this study, we aimed to define a minimal signature that could be used to distinguish melanoma sub-types in vitro, and to determine suitable drugs by which these sub-types can be targeted. By using prima...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C6MD00466K

    authors: Senses KM,Ghasemi M,Akbar MW,Isbilen M,Fallacara AL,Frankenburg S,Schenone S,Lotem M,Botta M,Gure AO

    更新日期:2017-01-01 00:00:00

  • Correction: Chiral ruthenium polypyridyl complexes as mitochondria-targeted apoptosis inducers.

    abstract::[This corrects the article DOI: 10.1039/C0MD00060D.]. ...

    journal_title:MedChemComm

    pub_type: 已发布勘误

    doi:10.1039/c8md90010h

    authors: Chen T,Mei WJ,Wong YS,Liu J,Liu Y,Xie HS,Zheng WJ

    更新日期:2018-03-19 00:00:00

  • The use of 111Ag as a tool for studying biological distribution of silver-based antimicrobials.

    abstract::Recently, there has been an emergence of significant interest in silver-based antimicrobials. Our goal was to develop a radioactive tracer for investigating the biological fate of such compounds. Purified 111Ag was incorporated into the methylated caffeine analogue, IC1 to yield the silver carbene complex designated a...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C3MD00082F

    authors: Aweda TA,Ikotun O,Mastren T,Cannon CL,Wright B,Youngs WJ,Cutler C,Guthrie J,Lapi SE

    更新日期:2013-06-01 00:00:00

  • Synthesis, conformational preferences, and biological activity of conformational analogues of the microtubule-stabilizing agents, (-)-zampanolide and (-)-dactylolide.

    abstract::Zampanolide and dactylolide are microtubule-stabilizing polyketides possessing potent cytotoxicity towards a variety of cancer cell lines. Using our understanding of the conformational preferences of the macrolide core in both natural products, we hypothesized that analogues lacking the C17-methyl group would maintain...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c9md00164f

    authors: Henry JL,Wilson MR,Mulligan MP,Quinn TR,Sackett DL,Taylor RE

    更新日期:2019-04-09 00:00:00

  • Repositioning Salirasib as a new antimalarial agent.

    abstract::Malaria is a serious tropical disease that kills thousands of people every year, mainly in Africa, due to Plasmodium falciparum infections. Salirasib is a promising cancer drug candidate that interferes with the post-translational modification of Ras. This S-farnesyl thiosalicylate inhibits isoprenylcysteine carboxyl ...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c9md00298g

    authors: Porta EOJ,Bofill Verdaguer I,Perez C,Banchio C,Ferreira de Azevedo M,Katzin AM,Labadie GR

    更新日期:2019-06-21 00:00:00

  • Exploring the effectiveness of novel benzimidazoles as CB2 ligands: synthesis, biological evaluation, molecular docking studies and ADMET prediction.

    abstract::Herein we continued our previous work on the development of CB2 ligands, reporting the design and synthesis of a series of benzimidazole-containing derivatives that were explored as selective CB2 ligands with binding affinity towards both CB1 and CB2 receptors. Seven out of eighteen compounds exhibited preferential bi...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00461g

    authors: Tonelli M,Cichero E,Mahmoud AM,Rabbito A,Tasso B,Fossa P,Ligresti A

    更新日期:2018-10-10 00:00:00

  • Synthesis and synergistic antifungal effects of monoketone derivatives of curcumin against fluconazole-resistant Candida spp.

    abstract::Twenty-three monoketone derivatives of curcumin were synthesized to investigate the synergy with fluconazole against fluconazole-resistant Candida spp. The minimal inhibitory concentration (MIC80) and the fractional inhibitory concentration index (FICI) of the antifungal synergist fluconazole were measured against flu...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c6md00649c

    authors: Zhao F,Dong HH,Wang YH,Wang TY,Yan ZH,Yan F,Zhang DZ,Cao YY,Jin YS

    更新日期:2017-03-17 00:00:00

  • Rationally synthesized coumarin based pyrazolines ameliorate carrageenan induced inflammation through COX-2/pro-inflammatory cytokine inhibition.

    abstract::In the present work, coumarin based pyrazolines (7a-g) have been synthesized and investigated for their in vitro and in vivo anti-inflammatory potential. Amongst the synthesized compounds, compounds 7a, 7d and 7f exhibited significant in vitro anti-inflammatory activity as compared to the standard etoricoxib. Keeping ...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00457a

    authors: Chandel P,Kumar A,Singla N,Kumar A,Singh G,Gill RK

    更新日期:2019-01-23 00:00:00

  • Benzophenone: a ubiquitous scaffold in medicinal chemistry.

    abstract::The benzophenone scaffold represents a ubiquitous structure in medicinal chemistry because it is found in several naturally occurring molecules which exhibit a variety of biological activities, such as anticancer, anti-inflammatory, antimicrobial, and antiviral. In addition, various synthetic benzophenone motifs are p...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c8md00300a

    authors: Surana K,Chaudhary B,Diwaker M,Sharma S

    更新日期:2018-08-23 00:00:00

  • Development of selective agents targeting serotonin 5HT1A receptors with subnanomolar activities based on a coumarin core.

    abstract::A series of 18 new 5-[3-(4-aryl-1-piperazinyl)propoxy]coumarin derivatives from the corresponding bromoalkyl derivatives have been designed and synthesized by us using a microwave-assisted protocol. Radioligand binding assays of this series of compounds as well as a previously synthesized series of 17 structurally-sim...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c7md00281e

    authors: Ostrowska K,Grzeszczuk D,Głuch-Lutwin M,Gryboś A,Siwek A,Dobrzycki Ł,Trzaskowski B

    更新日期:2017-07-03 00:00:00

  • Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity.

    abstract::Tetrahydroisoquinoline (THIQ) is a key structural component in many biologically active molecules including natural products and synthetic pharmaceuticals. Here, we report on the use of transition-metal mediated [2 + 2 + 2] cyclotrimerisation of alkynes to generate tricyclic THIQs with potential to selectively inhibit...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c9md00201d

    authors: Santos ARN,Sheldrake HM,Ibrahim AIM,Danta CC,Bonanni D,Daga M,Oliaro-Bosso S,Boschi D,Lolli ML,Pors K

    更新日期:2019-06-27 00:00:00

  • Coupling the cell-penetrating peptides transportan and transportan 10 to primaquine enhances its activity against liver-stage malaria parasites.

    abstract::Novel primaquine-cell penetrating peptide conjugates were synthesised and tested in vitro against liver stage Plasmodium berghei parasites. Generally, the conjugates were more active than the parent peptides and, in some cases, than the parent drug. These are unprecedented findings that may open a new route towards an...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00447a

    authors: Aguiar L,Machado M,Sanches-Vaz M,Prudêncio M,Vale N,Gomes P

    更新日期:2018-11-16 00:00:00

  • Microwave-enhanced Friedländer synthesis for the rapid assembly of halogenated quinolines with antibacterial and biofilm eradication activities against drug resistant and tolerant bacteria.

    abstract::Herein, we disclose the development of a catalyst- and protecting-group-free microwave-enhanced Friedländer synthesis which permits the single-step, convergent assembly of diverse 8-hydroxyquinolines with greatly improved reaction yields over traditional oil bath heating (increased from 34% to 72%). This rapid synthes...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c6md00381h

    authors: Garrison AT,Abouelhassan Y,Yang H,Yousaf HH,Nguyen TJ,Huigens Iii RW

    更新日期:2016-07-27 00:00:00

  • Effect of antimalarial drug primaquine and its derivatives on the ionization potential of hemoglobin: A QM/MM study.

    abstract::We used quantum mechanics/molecular mechanics calculations to test if antimalarial primaquine (PQ) and its derivatives aid the conversion of hemoglobin to methemoglobin by binding to hemoglobin and merely lowering hemoglobin's ionization potential (IP). Our results showed that PQ and its derivatives do not significant...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C3MD00045A

    authors: Liu H,Ding Y,Walker LA,Doerksen RJ

    更新日期:2013-08-01 00:00:00

  • A complex game of hide and seek: the search for new antifungals.

    abstract::Fungal infections directly affect millions of people each year. In addition to the invasive fungal infections of humans, the plants and animals that comprise our primary food source are also susceptible to diseases caused by these eukaryotic microbes. The need for antifungals, not only for our medical needs, but also ...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C6MD00222F

    authors: Ngo HX,Garneau-Tsodikova S,Green KD

    更新日期:2016-07-01 00:00:00

  • Novel lead compounds in pre-clinical development against African sleeping sickness.

    abstract::Human African trypanosomiasis (HAT), also known as African sleeping sickness, is caused by parasitic protozoa of the genus Trypanosoma. As the disease progresses, the parasites cross the blood brain barrier and are lethal for the patients if the disease is left untreated. Current therapies suffer from several drawback...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c7md00280g

    authors: Berninger M,Schmidt I,Ponte-Sucre A,Holzgrabe U

    更新日期:2017-07-31 00:00:00

  • Neuropilin-1 peptide-like ligands with proline mimetics, tested using the improved chemiluminescence affinity detection method.

    abstract::Many reports have suggested that NRP-1 acts as a co-receptor for VEGF-A165 and boosts tumour growth and metastasis. This NRP-1, due to its important role in tumour progression, triggered interest in the design of new molecules able to significantly inhibit NRP-1/VEGF-A165 interaction to suppress pathological angiogene...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00537k

    authors: Puszko AK,Sosnowski P,Tymecka D,Raynaud F,Hermine O,Lepelletier Y,Misicka A

    更新日期:2019-01-25 00:00:00

  • Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists.

    abstract::The dopamine D3 receptor (D3R) is a proven therapeutic target for the treatment of neurological and neuropsychiatric disorders. In particular, D3R-selective ligands that can eliminate side effects associated with dopamine D2 receptor (D2R) therapeutics have been validated. However, the high homology in signaling pathw...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00237a

    authors: Cao Y,Sun N,Zhang J,Liu Z,Tang YZ,Wu Z,Kim KM,Cheon SH

    更新日期:2018-06-14 00:00:00

  • Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance().

    abstract::A series of cyclic peptides were designed and prepared to investigate the physicochemical properties that affect oral bioavailabilty of this chemotype in rats. In particular, the ionization state of the peptide was examined by the incorporation of naturally occurring amino acid residues that are charged in differing r...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C2MD20203D

    authors: Rand AC,Leung SS,Eng H,Rotter CJ,Sharma R,Kalgutkar AS,Zhang Y,Varma MV,Farley KA,Khunte B,Limberakis C,Price DA,Liras S,Mathiowetz AM,Jacobson MP,Lokey RS

    更新日期:2012-10-01 00:00:00

  • Adaptive mechanisms of resistance to anti-neoplastic agents.

    abstract::Intrinsic and acquired resistance to conventional and targeted therapeutics is a fundamental reason for treatment failure in many cancer patients. Targeted approaches to overcome chemoresistance as well as resistance to targeted approaches require in depth understanding of the underlying molecular mechanisms. The anti...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c6md00394j

    authors: Ferreira BI,Lie MK,Engelsen AST,Machado S,Link W,Lorens JB

    更新日期:2016-10-21 00:00:00

  • Benzisoxazole: a privileged scaffold for medicinal chemistry.

    abstract::The benzisoxazole analogs represent one of the privileged structures in medicinal chemistry and there has been an increasing number of studies on benzisoxazole-containing compounds. The unique benzisoxazole scaffold also exhibits an impressive potential as antimicrobial, anticancer, anti-inflammatory, anti-glycation a...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c7md00449d

    authors: Rakesh KP,Shantharam CS,Sridhara MB,Manukumar HM,Qin HL

    更新日期:2017-10-31 00:00:00

  • Identification and biological evaluation of novel benzothiazole derivatives bearing a pyridine-semicarbazone moiety as apoptosis inducers via activation of procaspase-3 to caspase-3.

    abstract::Three series of compounds were designed, synthesized and evaluated for their in vitro anticancer activity against a procaspase-3 over-expression cancer cell line (U937) and a procaspase-3 no-expression cancer cell line (MCF-7) to rule out off-target effects. Biological evaluation led to the identification of a series ...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00624e

    authors: Ma J,Ni X,Gao Y,Huang K,Liu J,Wang Y,Chen R,Wang C

    更新日期:2019-02-25 00:00:00

  • Astemizole-based turn-on fluorescent probes for imaging hERG potassium channel.

    abstract::Based on the scaffold of astemizole, three novel turn-on fluorescent probes (N1-N3) for human ether-a-go-go-related gene (hERG) potassium channel were developed herein. These probes have reasonable fluorescence properties, acceptable cell toxicity, and potent inhibitory activity, all of which contribute to cell imagin...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00562a

    authors: Zhang X,Liu T,Wang B,Gao Y,Liu P,Li M,Du L

    更新日期:2019-02-26 00:00:00

  • Kaolin alleviates the toxicity of graphene oxide for mammalian cells.

    abstract::The development of novel nanoscale vehicles for drug delivery promotes the growth of interest in investigations of interaction between nanomaterials. In this paper, we report the in vitro studies of eukaryotic cell physiological response to incubation with graphene oxide and planar kaolin nanoclay. Graphene family mat...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00633d

    authors: Rozhina E,Batasheva S,Danilushkina A,Kryuchkova M,Gomzikova M,Cherednichenko Y,Nigamatzyanova L,Akhatova F,Fakhrullin R

    更新日期:2019-06-10 00:00:00

  • Potentiation of the Fosmidomycin analogue FR 900098 with substituted 2-oxazolines against Francisella novicida.

    abstract::A library of 33 compounds was screened for potentiation of the antibiotic FR 900098 against the Francisella tularensis surrogate Francisella novicida. From the screen a highly potent 2-oxazoline adjuvant was discovered capable of potentiating FR 900098 with a 1000-fold reduction in MIC against the Francisella sub-spec...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C6MD00365F

    authors: Stephens MD,Yodsanit N,Melander C

    更新日期:2016-01-01 00:00:00

  • Structure-Based Design, Synthesis by Click Chemistry and in Vivo Activity of Highly Selective A3 Adenosine Receptor Agonists.

    abstract::2-Arylethynyl derivatives of (N)-methanocarba adenosine 5'-uronamides are selective A3AR (adenosine receptor) agonists. Here we substitute a 1,2,3-triazol-1-yl linker in place of the rigid, linear ethynyl group to eliminate its potential metabolic liability. Docking of nucleosides containing possible short linker moie...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C4MD00571F

    authors: Tosh DK,Paoletta S,Chen Z,Crane S,Lloyd J,Gao ZG,Gizewski ET,Auchampach JA,Salvemini D,Jacobson KA

    更新日期:2015-01-01 00:00:00

  • Targeting the trehalose utilization pathways of Mycobacterium tuberculosis.

    abstract::Tuberculosis (TB) is an epidemic disease and the growing burden of multidrug-resistant (MDR) TB world wide underlines the need to discover new drugs to treat the disease. Mycobacterium tuberculosis (Mtb) is the etiological agent of most cases of TB. Mtb is difficult to treat, in part, due to the presence of a sturdy h...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C5MD00376H

    authors: Thanna S,Sucheck SJ

    更新日期:2016-01-01 00:00:00